Serina Therapeutics, Inc.(SER) - 2025 Q4 - Annual Results

Exhibit 99.1 Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported its financial results for the full year ended December 31, 2025 and provided recent business highlights. "This past year was defined by execution, advancing SER ...